Mild ischemic Injury Leads to Long-Term Alterations in the Kidney: Amelioration by Spironolactone Administration

Administration of the mineralocorticoid receptor antagonist spironolactone prevents the development of chronic kidney disease (CKD) after a severe ischemic injury. However, whether brief periods of ischemia lead to CKD and whether spironolactone administration after ischemia may be a useful therapeu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Biol Sci
Main Authors: Barrera-Chimal, Jonatan, Pérez-Villalva, Rosalba, Ortega, Juan Antonio, Sánchez, Andrea, Rodríguez-Romo, Roxana, Durand, Marta, Jaisser, Frederic, Bobadilla, Norma A.
Format: Artigo
Jezik:Inglês
Izdano: Ivyspring International Publisher 2015
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4495407/
https://ncbi.nlm.nih.gov/pubmed/26157344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijbs.11729
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki